Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B3,5 | Lung | Primary cancer | 135 | Other | 57.0% | 0.60 | 0.66 |
| NSCLC_38242124__IMC__178_B3,6 | Lung | Primary cancer | 2,768 | Stromal | 36.6% | 0.87 | 0.43 |
| NSCLC_38242124__IMC__178_B3,7 | Lung | Primary cancer | 3,326 | Tumor/Malignant | 28.1% | 0.94 | 0.17 |
| NSCLC_38242124__IMC__178_B3,8 | Lung | Primary cancer | 4,606 | Tumor/Malignant | 91.3% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__178_B3,9 | Lung | Primary cancer | 2,355 | Tumor/Malignant | 34.7% | 0.91 | 0.37 |
| NSCLC_38242124__IMC__178_B4,1 | Lung | Primary cancer | 1,958 | Tumor/Malignant | 43.6% | 0.91 | 0.29 |
| NSCLC_38242124__IMC__178_B4,10 | Lung | Primary cancer | 2,209 | Tumor/Malignant | 35.8% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__178_B4,11 | Lung | Primary cancer | 663 | Stromal | 32.6% | 0.38 | 0.85 |
| NSCLC_38242124__IMC__178_B4,12 | Lung | Primary cancer | 2,705 | Tumor/Malignant | 31.3% | 0.50 | 0.88 |
| NSCLC_38242124__IMC__178_B4,14 | Lung | Primary cancer | 2,098 | Tumor/Malignant | 37.1% | 0.94 | 0.17 |
| NSCLC_38242124__IMC__178_B4,15 | Lung | Primary cancer | 226 | Other | 55.3% | 0.46 | 0.75 |
| NSCLC_38242124__IMC__178_B4,16 | Lung | Primary cancer | 1,671 | Tumor/Malignant | 32.7% | 0.49 | 0.92 |
| NSCLC_38242124__IMC__178_B4,17 | Lung | Primary cancer | 2,366 | Stromal | 39.1% | 0.84 | 0.45 |
| NSCLC_38242124__IMC__178_B4,18 | Lung | Primary cancer | 2,977 | Tumor/Malignant | 56.2% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__178_B4,2 | Lung | Primary cancer | 1,749 | Tumor/Malignant | 53.5% | 0.95 | 0.17 |
| NSCLC_38242124__IMC__178_B4,3 | Lung | Primary cancer | 341 | Other | 50.4% | 0.56 | 0.76 |
| NSCLC_38242124__IMC__178_B4,4 | Lung | Primary cancer | 3,418 | Tumor/Malignant | 37.9% | 0.89 | 0.30 |
| NSCLC_38242124__IMC__178_B4,5 | Lung | Primary cancer | 2,425 | Tumor/Malignant | 63.0% | 0.88 | 0.28 |
| NSCLC_38242124__IMC__178_B4,6 | Lung | Primary cancer | 688 | Stromal | 38.8% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__178_B4,7 | Lung | Primary cancer | 3,747 | Tumor/Malignant | 51.9% | 0.96 | 0.12 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B3,5 | Lung | Primary cancer | 135 | Other | 70.4% | 0.55 | 0.69 |
| NSCLC_38242124__IMC__178_B3,6 | Lung | Primary cancer | 2,768 | Stromal | 26.8% | 0.92 | 0.32 |
| NSCLC_38242124__IMC__178_B3,7 | Lung | Primary cancer | 3,326 | Tumor/Malignant | 28.6% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__178_B3,8 | Lung | Primary cancer | 4,606 | Tumor/Malignant | 89.4% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__178_B3,9 | Lung | Primary cancer | 2,355 | Tumor/Malignant | 31.5% | 0.92 | 0.32 |
| NSCLC_38242124__IMC__178_B4,1 | Lung | Primary cancer | 1,958 | Tumor/Malignant | 35.7% | 0.95 | 0.24 |
| NSCLC_38242124__IMC__178_B4,10 | Lung | Primary cancer | 2,209 | Tumor/Malignant | 36.4% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__178_B4,11 | Lung | Primary cancer | 663 | Stromal | 31.2% | 0.38 | 0.85 |
| NSCLC_38242124__IMC__178_B4,12 | Lung | Primary cancer | 2,705 | Tumor/Malignant | 26.2% | 0.55 | 0.85 |
| NSCLC_38242124__IMC__178_B4,14 | Lung | Primary cancer | 2,098 | Tumor/Malignant | 37.7% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__178_B4,15 | Lung | Primary cancer | 226 | Other | 54.4% | 0.46 | 0.82 |
| NSCLC_38242124__IMC__178_B4,16 | Lung | Primary cancer | 1,671 | Other | 23.2% | 0.56 | 0.94 |
| NSCLC_38242124__IMC__178_B4,17 | Lung | Primary cancer | 2,366 | Stromal | 27.3% | 0.89 | 0.33 |
| NSCLC_38242124__IMC__178_B4,18 | Lung | Primary cancer | 2,977 | Tumor/Malignant | 56.2% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__178_B4,2 | Lung | Primary cancer | 1,749 | Tumor/Malignant | 50.6% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__178_B4,3 | Lung | Primary cancer | 341 | Other | 50.4% | 0.56 | 0.77 |
| NSCLC_38242124__IMC__178_B4,4 | Lung | Primary cancer | 3,418 | Tumor/Malignant | 39.0% | 0.89 | 0.32 |
| NSCLC_38242124__IMC__178_B4,5 | Lung | Primary cancer | 2,425 | Tumor/Malignant | 40.1% | 0.72 | 0.53 |
| NSCLC_38242124__IMC__178_B4,6 | Lung | Primary cancer | 688 | Stromal | 39.2% | 0.93 | 0.20 |
| NSCLC_38242124__IMC__178_B4,7 | Lung | Primary cancer | 3,747 | Tumor/Malignant | 49.1% | 0.97 | 0.09 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B3,5 | Lung | Primary cancer | 135 | Other | 51.9% | 0.63 | 0.66 |
| NSCLC_38242124__IMC__178_B3,6 | Lung | Primary cancer | 2,768 | Fibroblast | 33.9% | 0.86 | 0.45 |
| NSCLC_38242124__IMC__178_B3,7 | Lung | Primary cancer | 3,326 | Tumor/Malignant cell | 28.5% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__178_B3,8 | Lung | Primary cancer | 4,606 | Tumor/Malignant cell | 91.7% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__178_B3,9 | Lung | Primary cancer | 2,355 | Tumor/Malignant cell | 36.2% | 0.89 | 0.40 |
| NSCLC_38242124__IMC__178_B4,1 | Lung | Primary cancer | 1,958 | Tumor/Malignant cell | 45.8% | 0.91 | 0.30 |
| NSCLC_38242124__IMC__178_B4,10 | Lung | Primary cancer | 2,209 | Tumor/Malignant cell | 36.7% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__178_B4,11 | Lung | Primary cancer | 663 | Fibroblast | 32.3% | 0.36 | 0.88 |
| NSCLC_38242124__IMC__178_B4,12 | Lung | Primary cancer | 2,705 | Tumor/Malignant cell | 29.3% | 0.86 | 0.47 |
| NSCLC_38242124__IMC__178_B4,14 | Lung | Primary cancer | 2,098 | Tumor/Malignant cell | 42.8% | 0.92 | 0.26 |
| NSCLC_38242124__IMC__178_B4,15 | Lung | Primary cancer | 226 | Other | 54.4% | 0.46 | 0.84 |
| NSCLC_38242124__IMC__178_B4,16 | Lung | Primary cancer | 1,671 | Other | 23.4% | 0.55 | 0.96 |
| NSCLC_38242124__IMC__178_B4,17 | Lung | Primary cancer | 2,366 | Fibroblast | 38.9% | 0.84 | 0.45 |
| NSCLC_38242124__IMC__178_B4,18 | Lung | Primary cancer | 2,977 | Tumor/Malignant cell | 77.8% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__178_B4,2 | Lung | Primary cancer | 1,749 | Tumor/Malignant cell | 55.3% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__178_B4,3 | Lung | Primary cancer | 341 | Other | 50.4% | 0.56 | 0.79 |
| NSCLC_38242124__IMC__178_B4,4 | Lung | Primary cancer | 3,418 | Tumor/Malignant cell | 50.4% | 0.85 | 0.44 |
| NSCLC_38242124__IMC__178_B4,5 | Lung | Primary cancer | 2,425 | Tumor/Malignant cell | 56.6% | 0.91 | 0.25 |
| NSCLC_38242124__IMC__178_B4,6 | Lung | Primary cancer | 688 | Fibroblast | 37.4% | 0.93 | 0.21 |
| NSCLC_38242124__IMC__178_B4,7 | Lung | Primary cancer | 3,747 | Tumor/Malignant cell | 53.3% | 0.95 | 0.14 |